@article{507bca94049f4dc582fb3c59c590fe62,
title = "Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study",
keywords = "Atrial fibrillation, Quality of life, Risk factor, Targeted therapy, Randomized clinical trial, RHYTHM CONTROL, TRIAL, MANAGEMENT",
author = "{De With}, {Ruben R.} and Michiet Rienstra and Smit, {Marcelle D.} and Bob Weijs and Zwartkruis, {Victor W.} and Hobbelt, {Anne H.} and Marco Atings and Tijssen, {Jan G. P.} and Johan Brugemann and Bastiaan Geelhoed and Hillege, {Hans L.} and Raymond Tukkie and Hemels, {Martin E.} and Tieleman, {Robert G.} and Adetita Ranchor and {Van Veldhuisen}, {Dirk J.} and Crijns, {Harry J. G. M.} and {Van Gelder}, {Isabelle C.} and {RACE 3 Investigators}",
year = "2019",
month = apr,
doi = "10.1093/europace/euy311",
language = "English",
volume = "21",
pages = "563--571",
journal = "EP Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "4",
}